EG20234A - A process for preparing of stabilized hexadecylphosphocholine solution in glycerol olkyl ethers - Google Patents

A process for preparing of stabilized hexadecylphosphocholine solution in glycerol olkyl ethers

Info

Publication number
EG20234A
EG20234A EG66893A EG66893A EG20234A EG 20234 A EG20234 A EG 20234A EG 66893 A EG66893 A EG 66893A EG 66893 A EG66893 A EG 66893A EG 20234 A EG20234 A EG 20234A
Authority
EG
Egypt
Prior art keywords
glycerol
ethers
olkyl
hexadecylphosphocholine
stabilized
Prior art date
Application number
EG66893A
Other languages
English (en)
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of EG20234A publication Critical patent/EG20234A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EG66893A 1992-10-23 1993-10-19 A process for preparing of stabilized hexadecylphosphocholine solution in glycerol olkyl ethers EG20234A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4235911A DE4235911A1 (de) 1992-10-23 1992-10-23 Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern

Publications (1)

Publication Number Publication Date
EG20234A true EG20234A (en) 1998-05-31

Family

ID=6471239

Family Applications (1)

Application Number Title Priority Date Filing Date
EG66893A EG20234A (en) 1992-10-23 1993-10-19 A process for preparing of stabilized hexadecylphosphocholine solution in glycerol olkyl ethers

Country Status (14)

Country Link
US (1) US5446033A (xx)
EP (1) EP0593897B1 (xx)
JP (1) JPH06227987A (xx)
CN (1) CN1052878C (xx)
AT (1) ATE136784T1 (xx)
CA (1) CA2109053C (xx)
DE (2) DE4235911A1 (xx)
DK (1) DK0593897T3 (xx)
EG (1) EG20234A (xx)
ES (1) ES2086168T3 (xx)
GR (1) GR3020045T3 (xx)
RU (1) RU2114624C1 (xx)
SG (1) SG48779A1 (xx)
UA (1) UA27099C2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
FR2729050A1 (fr) * 1995-02-23 1996-07-12 Oreal Compositions resistant a la degradation microbienne
US6278004B1 (en) 1996-11-06 2001-08-21 Aventis Pharma Deutschland Gmbh Stabilized phospholipidic composition
DE10028638A1 (de) 2000-06-09 2001-12-20 Schuelke & Mayr Gmbh Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern
US7041302B2 (en) 2001-01-09 2006-05-09 Biother Corporation Therapeutic modulation of the tumor inflammatory response
DE10313272A1 (de) * 2003-03-24 2004-10-21 Baxter Healthcare S.A. Verwendung von Miltefosine zur Behandlung von aktinischer oder multiplen aktinischer Keratosen
JP2012532154A (ja) * 2009-07-09 2012-12-13 エキスパーゲン ドラッグ デベロプメント ゲーエムベーハー アルキルホスホコリンの液状医薬製剤及びその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008294A (en) * 1985-02-11 1991-04-16 Chemex Pharmaceuticals, Inc. Methods of treating tumors with compositions of catecholic butanes
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen

Also Published As

Publication number Publication date
UA27099C2 (uk) 2000-02-28
US5446033A (en) 1995-08-29
EP0593897B1 (de) 1996-04-17
DK0593897T3 (da) 1996-05-13
CN1090174A (zh) 1994-08-03
RU2114624C1 (ru) 1998-07-10
ATE136784T1 (de) 1996-05-15
JPH06227987A (ja) 1994-08-16
DE59302251D1 (de) 1996-05-23
CA2109053C (en) 2004-02-10
ES2086168T3 (es) 1996-06-16
CN1052878C (zh) 2000-05-31
SG48779A1 (en) 1998-05-18
GR3020045T3 (en) 1996-08-31
DE4235911A1 (de) 1994-04-28
CA2109053A1 (en) 1994-04-24
EP0593897A1 (de) 1994-04-27

Similar Documents

Publication Publication Date Title
HU896498D0 (en) Process for preparation of low volatility salts
EP0511430A3 (en) Cell preservative solution
AU1485295A (en) Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
EG20234A (en) A process for preparing of stabilized hexadecylphosphocholine solution in glycerol olkyl ethers
AU656493B2 (en) Regulation of immunoglobin production by interleukin-4 and interleukin-9
AU563692B2 (en) Bismuth containing composition and method for the preparationthereof
AU534930B2 (en) Use of aminophenol compounds as oxygen scavengers in an aqueous medium
JPS5544599A (en) Antiicorrosive agent for use in acid solution
AU5629690A (en) Carboplatin composition
DE3279616D1 (en) Stable oil-in-water dispersions
DE2962232D1 (en) The use of citric acid esters in cosmetic preparations
IL116169A (en) Free radical initiated process for the preparation of alkyl halodifluoroacetates
MY102330A (en) Surfactant composition and process for the production of oil using such a composition
DE3175900D1 (en) Indoloquinolizine derivatives, process for their preparation and their therapeutic use
IE790299L (en) Testosterone esters
DE3561948D1 (en) Oximinophosphoric acid derivatives, process for their preparation and their use as pesticides
PT70218A (en) Process for preparing an herbicidal composition containingn-(1,3-azolyl)-alkyl-halogenacetanilide
ES483822A1 (es) Procedimiento para la preparacion de nuevas sales estables
DE3264330D1 (en) Process for the preparation of cycloalkenon derivatives
JPS53121729A (en) Phenoxyphenoxypropionic acid derivatives and herbicides containing the same